Science Applications International Corp

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $148.0m $179.0m $137.0m $226.0m $209.0m $277.0m $300.0m $477.0m $362.0m $358.0m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $137.0m $229.0m $211.0m $279.0m $303.0m $477.0m $362.0m $358.0m
Net Income (Loss) Attributable to Noncontrolling Interest $0 $3.0m $2.0m $2.0m $3.0m $0 $0
Depreciation, Depletion and Amortization $24.0m $23.0m $23.0m $36.0m $32.0m $37.0m $32.0m $26.0m $25.0m $30.0m
Amortization $119.0m
Amortization of Debt Issuance Costs ($2.0m) $0 ($26.0m) $0 $21.0m $7.0m $9.0m $7.0m $0 ($9.0m)
Amortization of Intangible Assets $26.0m $21.0m $24.0m $95.0m $147.0m $128.0m $125.0m $115.0m $115.0m $119.0m
Other Depreciation and Amortization $24.0m $23.0m $23.0m $36.0m $32.0m $37.0m $32.0m $26.0m $3.0m $6.0m
Share-based Payment Arrangement, Noncash Expense $31.0m $27.0m $45.0m $37.0m $42.0m $46.0m $48.0m $68.0m $53.0m $64.0m
Goodwill and Intangible Asset Impairment $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Impairment of Intangible Assets, Finite-lived $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Operating Lease, Impairment Loss $1.0m $12.0m
Restructuring Costs and Asset Impairment Charges $21.0m $12.0m $19.0m $24.0m $23.0m $8.0m $35.0m
Gain (Loss) on Extinguishment of Debt ($2.0m) $0 ($4.0m) $0 $0
Gain (Loss) on Disposition of Business ($10.0m) $2.0m $0 $247.0m $0 $0
Gain (Loss) on Disposition of Property Plant Equipment ($1.0m) $0 $0 ($21.0m) ($46.0m) ($36.0m) ($25.0m) ($27.0m) ($36.0m) ($32.0m)
Income Tax Expense (Benefit) $72.0m $35.0m $33.0m $57.0m $60.0m $79.0m $72.0m $143.0m $66.0m $29.0m
Operating Lease, Lease Income $40.0m $18.0m $2.0m $0 $2.0m
Other Nonoperating Income (Expense) $1.0m $2.0m $3.0m $6.0m $3.0m $1.0m ($6.0m) ($1.0m) ($9.0m) ($6.0m)
Changes in operating assets and liabilities:
Noncash investing and financing activities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable ($96.0m) $135.0m $26.0m $50.0m ($221.0m) $31.0m ($79.0m) $46.0m $86.0m ($161.0m)
Proceeds from Stock Options Exercised $0 $0 $0 $0 $1.0m $0 $0 $1.0m
Purchases of property and equipment, accrued but unpaid $15.0m $22.0m $28.0m $21.0m $46.0m $36.0m $25.0m $27.0m $36.0m $32.0m
Deconsolidation, Gain (Loss), Amount $7.0m $7.0m
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $240.0m $0 $0
Goodwill $863.0m $863.0m $2.1b $2.1b $2.8b $2.9b $2.9b $2.9b $2.9b $2.9b
Restructuring Costs $16.0m $10.0m $1.0m $20.0m $23.0m $8.0m $12.0m
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement $1.0m
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax ($5.0m) ($2.0m)
Other Operating Income (Expense), Net ($4.0m) $3.0m $0 $3.0m $10.0m ($1.0m)
Net Cash Provided by (Used in) Operating Activities $273.0m $217.0m $184.0m $458.0m $755.0m $518.0m $532.0m $396.0m $494.0m $609.0m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $15.0m $22.0m $28.0m $21.0m $46.0m $36.0m $25.0m $27.0m $36.0m $32.0m
Payments to Acquire Businesses, Net of Cash Acquired $0 $0 $1.0b $0 $1.2b $255.0m $0 $0 $203.0m
Payments for (Proceeds from) Other Investing Activities ($1.0m) $5.0m $3.0m $6.0m $8.0m $5.0m $7.0m $0
Net Cash Provided by (Used in) Investing Activities ($17.0m) ($22.0m) ($1.0b) ($47.0m) ($1.2b) ($292.0m) ($36.0m) $314.0m ($35.0m) ($248.0m)
Cash flows from financing activities:
Proceeds from Issuance of Common Stock $5.0m $6.0m $7.0m $10.0m $13.0m $16.0m $16.0m $17.0m $20.0m $22.0m
Payments for Repurchase of Common Stock $180.0m $186.0m $69.0m $197.0m $34.0m $226.0m $267.0m $382.0m $558.0m $445.0m
Payments of Ordinary Dividends, Common Stock $54.0m $54.0m $53.0m $87.0m $87.0m $86.0m $83.0m $79.0m $75.0m $70.0m
Proceeds from Noncontrolling Interests $1.0m
Proceeds from (Payments to) Noncontrolling Interests ($7.0m) ($2.0m) ($2.0m) ($3.0m) $0
Proceeds from (Payments for) Other Financing Activities ($3.0m) ($4.0m)
Net Cash Provided by (Used in) Financing Activities ($247.0m) ($261.0m) $938.0m ($455.0m) $464.0m ($301.0m) ($493.0m) ($725.0m) ($498.0m) ($235.0m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $9.0m ($66.0m) $94.0m ($44.0m) ($12.0m) ($75.0m) $3.0m ($15.0m) ($39.0m) $126.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.0m $152.0m $246.0m $202.0m $190.0m $115.0m $118.0m $103.0m $64.0m $190.0m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $48.0m $41.0m $44.0m $86.0m $96.0m $98.0m $111.0m $125.0m $121.0m $101.0m
Income Taxes Paid, Net $22.0m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.